BioCardia, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.6M | $-2.3M | $-1.5M | $-2.0M | $-2.7M | $-1.7M | $-1.6M | $-2.3M |
| Depreciation & Amortization | — | $3.0K | — | — | $12.0K | — | — | $19.0K |
| Depreciation | — | — | $4.0K | $5.0K | $12.0K | $16.0K | $17.0K | $19.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $113.0K | — | — | $170.0K | — | — | $204.0K |
| Net Cash from Operating Activities | $-1.7M | $-1.7M | $-1.7M | $-1.6M | $-1.6M | $-2.6M | $-1.3M | $-1.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $3.0K | $0 | $1.0K | $0 | $2.0K | $3.0K | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-3.0K | — | — | $0 | — | — | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $117.0K | — | — | $196.0K | — | — | $1.4M |
| Net Change in Cash | — | $-1.5M | — | — | $-1.4M | — | — | $-154.0K |
| Free Cash Flow | $-1.7M | $-1.7M | $-1.7M | $-1.7M | $-1.6M | $-2.6M | $-1.3M | $-1.5M |